SAMN47320890
External Id
dbGaP
INSDC center name
2025-03-12T12:11:20.797Z
INSDC first public
2025-04-25T10:04:01.393Z
INSDC last update
SRS24353452
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS24353452
SRA accession
RNA
analyte type
NCI_AtezolizumabNeoantigen_UrothelialCancer
biospecimen repository
S29
biospecimen repository sample id
Bladder
body site
phs003922
gap_accession
1
gap_consent_code
HMB
gap_consent_short_name
7559601
gap_sample_id
5602626
gap_subject_id
Yes
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
male
sex
Clinical Trial
study design
Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with Urothelial Cancer: a Phase 1 Trial
study name
S29
submitted sample id
GU011
submitted subject id
NCI_AtezolizumabNeoantigen_UrothelialCancer
submitter handle
Tumor RNA sample from Bladder of a human male participant in the dbGaP study "Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with Urothelial Cancer: a Phase 1 Trial"
title